FDA Inspection
Quagen Pharma, LLCQuagen Pharma, LLC – FDA Inspection, Mar 15, 2019
Record Details
This FDA Inspection record concerns Quagen Pharma, LLC, with an inspection on March 15, 2019, issued by the New Jersey District Office, covering human drugs.
- People
- Amit Kokate (Issuing Officer)
- Mesfin Abdi (Issuing Officer)
- Monika Borkowska Petrik (Issuing Officer)
- Yvesna C. Blaise (Issuing Officer)
View Company Profile
ID · 1b77c1e2-436d-44c5-8066-9224307f23b0
Inspection Facts
- Inspection number
- 1082687
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Quagen Pharma, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 17, 2026 | Not classified | New Jersey District Office | |
| May 9, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 26, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Quagen Pharma, LLC
- FDA Inspection 1306964 - 2026-04-17
- FDA Inspection 1207909 - 2023-05-09
- FDA Inspection 1131910 - 2020-10-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.